nervous system
• no detectable plaques at 12 months of age compared to minimal levels in mice carrying the transgene alone
• 41-51% reduction in beta-amyloid at 16 months as compared to transgene controls
• reduced numbers of large and medium sized plaques in the neocortex and hippocampus
• beta-CTF is reduced relative to alpha-CTF
|
homeostasis/metabolism
• no detectable plaques at 12 months of age compared to minimal levels in mice carrying the transgene alone
• 41-51% reduction in beta-amyloid at 16 months as compared to transgene controls
• reduced numbers of large and medium sized plaques in the neocortex and hippocampus
• beta-CTF is reduced relative to alpha-CTF
|